Scotland to Host Research Challenge Using the Most Comprehensive Set of Dementia Biomarker Data in the World

  The Global Alzheimer's Platform Foundation® (GAP) has announced that Scotland will host the Bio-Hermes Biomarker Data Challenge 2024, a groundb...

March 26, 2024 | Tuesday | News
Elegen Launches ENFINIA™ DNA Enhancement Enabling Rapid Synthesis of Highly Complex DNA

    Gilles Besin, Ph.D., CSO at Orbital: “Elegen's unique expertise in supplying...IVT-ready synthetic DNA constructs is very attractive ...

March 21, 2024 | Thursday | News
Merck Commits Over €300 Million to Establish Cutting-Edge Life Science Production Hub in South Korea

  Matthias Heinzel, Member of the Executive Board of Merck and CEO Life Science, emphasized the strategic importance of this move, stating, "The Asia...

March 21, 2024 | Thursday | News
Clarity Pharmaceuticals Advances Theranostic Prostate Cancer Trial to Multi-Dose Phase

    The completion of Cohort 3 marks a significant milestone, with six participants receiving therapy with 67Cu-SAR-bisPSMA at the highest sing...

March 18, 2024 | Monday | News
Fennec and Norgine Partner to Commercialize PEDMARQSI in Europe, Australia, and NZ

Agreement pairs Norgine’s commercial expertise and leading European footprint with PEDMARQSI®, the first and only approved therapy in the Europea...

March 18, 2024 | Monday | News
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company specializing in endocrine diseases and tumors, revealed encouraging...

March 13, 2024 | Wednesday | News
Sanofi's Amlitelimab Shows Long-Term Efficacy in Atopic Dermatitis Treatment, Shaping Future Therapeutic Strategies

  New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis Late-breaking dat...

March 11, 2024 | Monday | News
Oxford Nanopore Launches PromethION 2 Integrated Sequencing Device

Oxford Nanopore Technologies announced the early access launch of its all-in-one desk top sequencing device, the PromethION 2 Integrated (P2i) to complete ...

March 08, 2024 | Friday | News
Epsilogen, Lonza Scale Up MOv18 IgE for Ovarian Cancer

GMP material to be used in Phase Ib study in platinum-resistant ovarian cancer (PROC) patients scheduled to start this year. Previously reported Phase I sa...

March 05, 2024 | Tuesday | News
Alamar Biosciences Partners with ALZpath to Advance Alzheimer's Diagnostic Solutions

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic supply agreemen...

March 04, 2024 | Monday | News
Inoviv Launches NeuroKey-3™: Pioneering Precision in Alzheimer's Biomarker Analysis

NeuroKey-3™ measures key biomarkers implicated in neurodegeneration, covering multiple aspects of Alzheimer's Disease and Dementia pathology, ...

March 04, 2024 | Monday | News
Clinical Microbiomics A/S Acquires DNASense, Expanding Frontiers in Microbiome Science Across Diverse Ecosystems

Clinical Microbiomics A/S^1, the global microbiome science company,  announces the acquisition of DNASense ApS, an innovative Danish microbiome C...

March 04, 2024 | Monday | News
Medidata and Thermo Fisher's PPD Business Partner to Boost Clinical Trials Innovation

-Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, today announced it has renewe...

February 29, 2024 | Thursday | News
Viatris and Idorsia Forge Major Global R&D Alliance to Enhance Innovative Drug Portfolio

    Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selato...

February 28, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close